| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
19,301 |
17,060 |
$1.80M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
11,052 |
10,327 |
$793K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
5,868 |
5,857 |
$460K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
5,080 |
5,075 |
$400K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
4,551 |
4,365 |
$327K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,087 |
3,082 |
$265K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
8,188 |
8,136 |
$153K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
10,730 |
10,106 |
$147K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
12,927 |
12,781 |
$134K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,101 |
3,066 |
$127K |
| 99215 |
Prolong outpt/office vis |
724 |
714 |
$105K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,647 |
2,004 |
$57K |
| 99381 |
|
631 |
630 |
$56K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,251 |
1,209 |
$51K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,291 |
6,142 |
$41K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,546 |
3,474 |
$33K |
| 90473 |
|
3,287 |
3,284 |
$25K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,059 |
1,979 |
$22K |
| 83655 |
|
1,834 |
1,825 |
$19K |
| 99188 |
|
2,623 |
2,618 |
$19K |
| 92552 |
|
778 |
777 |
$17K |
| 90677 |
|
453 |
451 |
$16K |
| 81002 |
|
3,939 |
3,831 |
$10K |
| 0001A |
|
262 |
262 |
$10K |
| 96127 |
|
3,125 |
3,103 |
$9K |
| 99000 |
|
7,677 |
7,021 |
$9K |
| 0002A |
|
231 |
231 |
$9K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
380 |
361 |
$9K |
| 99051 |
|
2,440 |
2,385 |
$8K |
| 92587 |
|
678 |
673 |
$7K |
| 87081 |
|
1,337 |
1,283 |
$7K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
64 |
64 |
$6K |
| 99177 |
|
4,449 |
4,437 |
$6K |
| 36415 |
Collection of venous blood by venipuncture |
1,946 |
1,903 |
$5K |
| 0071A |
|
107 |
107 |
$4K |
| 87807 |
|
494 |
487 |
$4K |
| 81003 |
|
2,052 |
1,972 |
$4K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
63 |
63 |
$3K |
| 0072A |
|
77 |
77 |
$3K |
| 90480 |
|
58 |
58 |
$2K |
| 87634 |
|
40 |
39 |
$2K |
| 69210 |
|
59 |
58 |
$2K |
| 0124A |
|
41 |
41 |
$2K |
| 80061 |
Lipid panel |
242 |
241 |
$2K |
| 96160 |
|
1,113 |
1,078 |
$1K |
| 99383 |
|
12 |
12 |
$1K |
| G9008 |
Coordinated care fee, physician coordinated care oversight services |
158 |
157 |
$514.86 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
28 |
28 |
$482.53 |
| 90620 |
|
630 |
630 |
$396.44 |
| 96380 |
|
18 |
18 |
$372.68 |
| 90672 |
|
642 |
642 |
$328.02 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
30 |
27 |
$327.60 |
| 91320 |
|
28 |
28 |
$270.00 |
| 96161 |
|
1,352 |
1,338 |
$258.90 |
| 90651 |
|
1,411 |
1,406 |
$252.27 |
| 90661 |
|
316 |
316 |
$243.24 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
25 |
25 |
$193.56 |
| 99050 |
|
49 |
49 |
$185.00 |
| 90715 |
|
617 |
617 |
$164.82 |
| 90686 |
|
4,879 |
4,862 |
$146.17 |
| 90674 |
|
600 |
600 |
$103.85 |
| 99441 |
|
12 |
12 |
$98.99 |
| 36416 |
|
343 |
325 |
$45.00 |
| 90734 |
|
1,336 |
1,335 |
$0.00 |
| 90710 |
|
586 |
585 |
$0.00 |
| 90633 |
|
2,206 |
2,201 |
$0.00 |
| 99072 |
|
7,531 |
6,304 |
$0.00 |
| 91300 |
|
376 |
364 |
$0.00 |
| 90670 |
|
3,280 |
3,270 |
$0.00 |
| 99173 |
|
4,435 |
4,425 |
$0.00 |
| 90707 |
|
953 |
950 |
$0.00 |
| 90685 |
|
49 |
49 |
$0.00 |
| 91312 |
|
28 |
28 |
$0.00 |
| 90700 |
|
14 |
14 |
$0.00 |
| 90698 |
|
3,285 |
3,278 |
$0.00 |
| 90696 |
|
767 |
766 |
$0.00 |
| 90723 |
|
52 |
52 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
1,823 |
1,817 |
$0.00 |
| 90680 |
|
2,392 |
2,387 |
$0.00 |
| 90744 |
|
2,052 |
2,044 |
$0.00 |
| 3008F |
|
2,374 |
2,342 |
$0.00 |
| 90716 |
|
1,059 |
1,058 |
$0.00 |
| 97802 |
|
2,714 |
2,696 |
$0.00 |
| 3048F |
|
176 |
176 |
$0.00 |
| 90660 |
|
195 |
195 |
$0.00 |
| 91307 |
|
206 |
186 |
$0.00 |
| 91305 |
|
34 |
34 |
$0.00 |
| 90647 |
|
12 |
12 |
$0.00 |